Volume | 6,950 |
|
|||||
News | - | ||||||
Day High | 0.0002 | Low High |
|||||
Day Low | 0.000001 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Q BioMed Inc (CE) | QBIO | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.000001 | 0.000001 | 0.0002 | 0.000001 | 0.0006 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4 | 6,950 | $ 0.000001 | $ 0.0063 | - | 0.000001 - 0.0155 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:23:00 | seq | 400 | $ 0.0002 | USD |
Q BioMed Inc (CE) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 145.09M | 41.00M | 284k | -3.49M | -0.02 | 0.00 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Q BioMed (CE) News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QBIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0005 | 0.0006 | 0.000001 | 0.000519 | 24,675 | -0.0005 | -99.80% |
1 Month | 0.000001 | 0.0006 | 0.000001 | 0.0004846 | 12,454 | 0.00 | 0.00% |
3 Months | 0.0001 | 0.0006 | 0.000001 | 0.0001245 | 61,459 | -0.0001 | -99.00% |
6 Months | 0.0003 | 0.0012 | 0.000001 | 0.0004551 | 112,132 | -0.0003 | -99.67% |
1 Year | 0.011 | 0.0155 | 0.000001 | 0.0052892 | 112,881 | -0.011 | -99.99% |
3 Years | 0.93 | 1.06 | 0.000001 | 0.0454805 | 574,997 | -0.93 | -100.00% |
5 Years | 1.665 | 3.75 | 0.000001 | 0.2260123 | 374,204 | -1.66 | -100.00% |
Q BioMed (CE) Description
Q BioMed Inc. ''Q`` is a biomedical acceleration and development company focused on acquiring companies and biomedical assets in clinical stage or and near revenue development. Q is dedicated to providing these target companies strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential enabling them to provide products to patients in need. |